Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses-Reference-Cited by-同舟云学术

Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses

Published:2015-10 Issue:10 Volume:23 Page:1630-1640
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Woller Norman,Gürlevik Engin,Fleischmann-Mundt Bettina,Schumacher Anja,Knocke Sarah,Kloos Arnold M,Saborowski Michael,Geffers Robert,Manns Michael P,Wirth Thomas C,Kubicka Stefan,Kühnel Florian

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

4. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study;Lynch;J Clin Oncol,2012

5. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer;Powles;Nature,2014

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes;Journal of Biochemical and Molecular Toxicology;2024-05-19

2. Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective study;2024-03-05

3. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells;Frontiers in Oncology;2024-01-31

4. TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model;Frontiers in Immunology;2024-01-22

5. Personalised neoantigen‐based therapy in colorectal cancer;Clinical and Translational Medicine;2023-11